OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Statins and risks of dementia among patients with heart failure: a population-based retrospective cohort study in Hong Kong
Q W Ren, Tiew‐Hwa Katherine Teng, Yi-Kei Tse, et al.
The Lancet Regional Health - Western Pacific (2024) Vol. 44, pp. 101006-101006
Open Access | Times Cited: 14

Showing 14 citing articles:

Alzheimer’s disease and its treatment–yesterday, today, and tomorrow
A. Y. Kim, Salman Al Jerdi, Ryan B. MacDonald, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 18

Statin use and dementia risk: A systematic review and updated meta‐analysis
Fernando Luiz Westphal Filho, Paulo Roberto Moss Lopes, Artur Menegaz de Almeida, et al.
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 1

Impact of heart failure medications on cognitive function: A systematic review
Soodeh Jahangiri, Э. Н. Казаков, Saipranusha Amancherla, et al.
European Journal of Clinical Investigation (2025)
Closed Access

Statins Reduce Delirium Risk in Older Adults With Type 2 Diabetes
Mingyang Sun, Xiaoling Wang, Zhongyuan Lu, et al.
Journal of the American Medical Directors Association (2025) Vol. 26, Iss. 4, pp. 105490-105490
Closed Access

A gut feeling of statin
Jianqing She, Lizhe Sun, Yue Yu, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2

Enhancing the human health and lifespan: a targeted strategy emphasizing statins
Edward J. Calabrese, Peter Pressman
Biogerontology (2024) Vol. 25, Iss. 5, pp. 883-890
Closed Access | Times Cited: 1

HMG-CoA reductase inhibitor simvastatin ameliorates trimethyltin neurotoxicity and cognitive impairment through reversal of Alzheimer’s-associated markers
Ali‐Akbar Salari, Mehrdad Roghani, Mohsen Khalili
Metabolic Brain Disease (2024) Vol. 40, Iss. 1
Closed Access | Times Cited: 1

Statins for vascular dementia: A hype or hope
Haroon Raja, Hayder M. Al‐kuraishy, Mustafa M Shokr, et al.
Neuroscience (2024) Vol. 567, pp. 45-55
Open Access | Times Cited: 1

Association Between Statin Use and Dementia, and Related Mechanisms: A Bibliometric Analysis from 2007 to 2023
Xianzheng Sang, Wen Chen, Xiaoxiang Hou, et al.
Journal of Alzheimer s Disease (2024), pp. 1-30
Closed Access

Association Between Carotid Plaque and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers and Cognitive Function in Cognitively Intact Adults: The CABLE Study
Cheng-Kun Sun, Fan Guo, Ya‐Nan Ou, et al.
Journal of Alzheimer s Disease (2024) Vol. 100, Iss. 1, pp. 207-217
Closed Access

Targeted inference to identify drug repositioning candidates in the Danish health registries
Alexander W. Jung, Ioannis Louloudis, Søren Brunak, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Medication Exposure and Risk of Dementia and Alzheimer’s Disease
Niti Sharma, Seong Soo A. An, SangYun Kim
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 23, pp. 12850-12850
Open Access

Page 1

Scroll to top